Opioid Consumption After Knee Arthroscopy

NCT03299920 | Completed

• 1 other identifier: IRB17-00710
• Study Type: interventional
• Target: 17
• Locations: 1 country
• Sites: 1

Brief Summary

This is a prospective, randomized trial of patients undergoing outpatient knee arthroscopy surgery and receiving a peripheral nerve block. Patients will be randomized to either receive standard discharge teaching or specialized teaching regarding pain control following a nerve block. Patients will be asked to complete a journal for 5 days recording their pain scores, opioid medication usage, and overall satisfaction with pain control at home.

Conditions

Surgical Procedure, Unspecified; Orthopedic Disorder

Outcome Measures

Primary Outcomes (1)

• Number of opioid medication doses taken

  Post-op day 5

Study Arms (2)

Intervention

ACTIVE COMPARATOR

Patients will receive standardized instruction from a study nurse, tailored to understanding pain management after nerve blocks and maximizing utilization of non-opioid analgesics.

Other: Standardized instructions

Control

OTHER

Patient will receive conventional instructions on postoperative pain management.

Other: Conventional instructions

Interventions

Standardized instructions OTHER

Specific instructions related to peripheral nerve block.

Intervention

Conventional instructions OTHER

Usual post-operative instructions.

Control

Eligibility Criteria

• Age: Up to 20 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Patient of age less than 20 years presenting to NCH main campus for knee arthroscopy
• American Society of Anesthesiology physical status I or II

You may not qualify if:

• Anterior cruciate ligament repair or reconstruction
• Admission to hospital
• Inability or refusal to receive femoral nerve blockade
• Body mass index \> 99 percentile
• Hydrocodone allergy or intolerance
• Acetaminophen allergy or intolerance
• Non-steroidal anti-inflammatory allergy or intolerance
• Pregnancy
• Interpreter requirement
• Opioid use within 3 months prior to surgery
• Previous knee surgery at WSC after Jan. 1, 2017
• History of opioid abuse or dependence

Sponsors & Collaborators

• Giorgio Veneziano: lead

Study Sites (1)

Nationwide Children's Hospital

Columbus, Ohio, 43205, United States

Location

MeSH Terms

Conditions

Musculoskeletal Diseases

Study Officials

• Giorgio Veneziano, MD

  Nationwide Children's Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Director, Regional Anesthesia Service

Study Record Dates

• First Submitted: September 28, 2017
• First Posted: October 3, 2017
• Study Start: September 18, 2017
• Primary Completion: October 22, 2018
• Study Completion: October 28, 2018
• Last Updated: October 23, 2019

Record last verified: 2019-10

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)